0001209191-24-000366.txt : 20240103 0001209191-24-000366.hdr.sgml : 20240103 20240103162010 ACCESSION NUMBER: 0001209191-24-000366 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231229 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARCIA PETER S CENTRAL INDEX KEY: 0001188956 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39386 FILM NUMBER: 24506738 MAIL ADDRESS: STREET 1: ALX ONCOLOGY HOLDINGS INC. STREET 2: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC CENTRAL INDEX KEY: 0001810182 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 850642577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-466-7125 MAIL ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-29 0 0001810182 ALX ONCOLOGY HOLDINGS INC ALXO 0001188956 GARCIA PETER S C/O ALX ONCOLOGY HOLDINGS INC. 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Financial Officer 0 Common Stock 2023-12-29 4 S 0 1893 15.04 D 85348 D The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. Includes 503 shares acquired under the Issuer's employee stock purchase plan on December 29, 2023. /s/ Peter Garcia 2024-01-03